ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

BRH Braveheart Investment Group Plc

5.00
0.00 (0.00%)
24 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Braveheart Investment Group Plc LSE:BRH London Ordinary Share GB00B13XV322 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 5.00 4.00 6.00 5.00 5.00 5.00 99,311 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Management Services 51k 1.59M 0.0249 2.01 3.19M
Braveheart Investment Group Plc is listed in the Management Services sector of the London Stock Exchange with ticker BRH. The last closing price for Braveheart Investment was 5p. Over the last year, Braveheart Investment shares have traded in a share price range of 4.10p to 15.75p.

Braveheart Investment currently has 63,723,489 shares in issue. The market capitalisation of Braveheart Investment is £3.19 million. Braveheart Investment has a price to earnings ratio (PE ratio) of 2.01.

Braveheart Investment Share Discussion Threads

Showing 3751 to 3773 of 3775 messages
Chat Pages: 151  150  149  148  147  146  145  144  143  142  141  140  Older
DateSubjectAuthorDiscuss
21/5/2024
17:27
I think TB has an arrangement with mm to take all sells hence the large sell figure of sells lumped together that has not made much difference to share price I think in due course we will see rns disclosure that his family firm FAB I think it is have added x amount of shares followed soon after with one that we have fantastic sales/orders or an offer to buy. All that's gone on of late has TB swizz all over it imo.
chavitravi2
16/5/2024
15:46
smash and grab raid , text book stuff ,read his book ' how to make money share dealing by trevor '
casino444
16/5/2024
14:25
Cash raise or surprise sale. Take your pick!
targatarga
16/5/2024
14:10
I reckon Trev and family will snap these up now if he's true to form. Get ready for an rns of something miraculous regarding Paratec or something in the coming months.
chavitravi2
15/5/2024
22:57
He's operating just the same way on IQAI
festario
15/5/2024
17:04
kemche - 04 May 2021 - 09:11:14 - 2616 of 3284 Braveheart Investment Group 2012 - BRH

This is clearly fantastic news and shows the imminence of the Paraytec tests - the results of which clearly TB knew nothing about. The imminence is now slightly delayed until after the further testing and a further six months after the signing of a contract. But after that it will be all whooshing all day. But only after that. Until then it is alive money.

Good old TB. What a man.

kemche
15/5/2024
17:03
Classic Trevor.
kemche
15/5/2024
16:35
Another TB story.
clocktower
15/5/2024
13:05
not a good rns ...why not just wait and include in results.

This could drop significantly today. Those selling today take a look at KRS and KDNC you can make your money up as they have double bagger potential

citys2874
15/5/2024
13:05
horrible news but when others are selling , mr trevor is in the background ready to pounce , director buy on way
casino444
15/5/2024
12:38
Cardiac arrest - Cremation soon?
pugugly
09/5/2024
12:35
In the tip?
kemche
04/3/2024
08:19
We have been done over with the Sale!
urchin1
08/2/2024
10:27
SYME IS NOW READY TO FLY
vaston
08/2/2024
10:23
Ready to pop?
targatarga
29/12/2023
11:35
Given that the Paraytec gizmo was designed to detect more than sepsis it could be worth anything to the right company. Imo 30p+ a share would be fair value.
chavitravi2
29/12/2023
09:50
Is that 3p a share then? Didnt we invest £2.5m in this?
chavitravi2
22/12/2023
18:23
£2.1m cash / 64m shs = 0.032p
euclid5
22/12/2023
09:31
If sale of this goes through that's 2.1 million cash after costs Market cap of Braveheart is 5 million.Paraytec will hopefully be a lot more.
targatarga
22/12/2023
08:57
Surprised these haven't risen more on this!
targatarga
20/12/2023
02:48
There is increasing interest in the the development of diagnostics for people with blood-borne bacterial infections. If left untreated, patients will develop sepsis - an acute and life-limiting physiological response which arises from inflammatory signals generated by the immune system. These signals emerge as neutrophils - specialised white blood cells - try to contain the infection, which they do by committing suicide and in so doing extruding their DNA and cellular content to generate a physical net or trap that catches and kills infecting bacteria.



For clinicians, people with blood with blood-borne infections present two challenges:-

(i) what is the nature of the infection (bacteraemia) and how to bring it under control, and

(ii) whether an infection will precipitate sepsis, requiring acute treatment to ensure the patient can avoid septic shock and survive long enough to allow for (i) to happen.



When clinicians suspect bacteraemia, the major challenge is concerned with diagnosis and identification of the infectious species, which determines the nature of antibiotic treatment required. At present, this takes up to 48h and involves lengthy culture of blood samples to enable specific identification of the bacteria present.



The recent reports of tests for sepsis ( specfically designed to detect the traps set by dying neutrophils, enabling clinicians to treat the life-threatening aspects of sepsis which include a sudden drop in blood pressure, blood-clotting, blood vessel damage and tissue/organ failure. These tests are complementary to the approach adopted by Paraytec Ltd , and allow clinicians to address (ii) but do nothing to address (i).



The Paraytec test is designed to address the issue outlined in (i), using molecular diagnostics and highly sensitive optical imaging to detect the presence of bacteria in samples obtained from blood without prior culture, and to distinguish Gram + from Gram - bacteria. Knowing the Gram status of organisms allows clinicians to make key decisions about antibiotic selection, as well as to suggest the source of infection enabling additional interventional measures.

ydderf
14/12/2023
08:26
Interesting trading statement ref decision to sell paraytec; should see some buying ahead of further news; time to load up
mdw1
19/9/2023
14:27
What a bargain these are just now with all the things we have coming good. when we get half decent news this will double easy. There are at least 3 projects ready to pop.
chavitravi2
Chat Pages: 151  150  149  148  147  146  145  144  143  142  141  140  Older

Your Recent History

Delayed Upgrade Clock